The selective interaction of nanomaterials with proteins for protein function suppression has
been reported. However, whether the nanomaterials could be used to target a three …

The receptor-binding domain (RBD) of the SARS-CoV-2 spike protein plays a crucial role in
binding the human cell receptor ACE2 that is required for viral entry. Many studies have …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters human cells upon
binding of its spike (S) glycoproteins to ACE2 receptors. Several nanobodies neutralize …

Herein, we fabricate host-directed virus-mimicking particles (VMPs) to block the entry of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells through …

The lack of targeting efficacy has frequently led functionalized nanoparticles to accumulate
in unwanted cells and tissues while boosting toxicity-related effects. Conversely, viruses are …

In the past two decades, the emergence of coronavirus diseases has been dire distress on
both continental and global fronts and has resulted in the search for potent treatment …

The widespread coronavirus disease 2019 (COVID-19) has been declared a global health
emergency. As one of the most important targets for antibody and drug developments, the …

Coronavirus disease 2019 (COVID-19) has caused a global pandemic of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The viral infection is reliant upon the …

Rationale: Macrophages are the frontline immune cells in response to severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Angiotensin-converting …

The major challenge to controlling the COVID pandemic is the rapid mutation rate of the
SARS-CoV-2 virus, leading to the escape of the protection of vaccines and most of the …